exudative maculopathy
Conditions
Interventions
None listed
Sponsors
Nagoya University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who visit a study participating facility between April 1, 2018, and September 30, 2021, and are diagnosed with exudative maculopathy will be included in the study.
Exclusion criteria
Exclusion criteria: Patients who refused to participate in the study will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sex, age, visual acuity, visual field, refraction, corneal curvature radius, corneal thickness, ocular axial length, fundus observation, Optical coherence tomography, optical coherence tomography angiography, fundus photograph, fluorescence fundus angiography, slit-lamp microscopy, duration of disease, current medical history, past history, family history, a medication used, frequency of dosing | — |
Countries
Japan
Contacts
Public ContactJun Takeuchi
Nagoya University Hospital Department of Ophthalmology
Outcome results
None listed